Send me a link:

*Text messaging rates may apply.

 Dow Up0.21% Nasdaq Up0.44%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.91 Up 0.01(0.83%) 9:42AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development5,340  7,711  4,989  
Selling General and Administrative4,121  4,115  3,637  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (9,460) (11,827) (8,626)
Income from Continuing Operations
Total Other Income/Expenses Net660  (2,271)2,906  
Earnings Before Interest And Taxes(8,801)(14,098)(5,720)
Interest Expense -  397   -  
Income Before Tax(8,801)(14,495)(5,720)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(8,801)(14,495)(5,720)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (8,801) (14,495) (5,720)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (8,801) (14,495) (5,720)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.